CL2020002876A1 - Vacuna contra la bronquitis infecciosa (divisional de la solicitud no. 201803420) - Google Patents
Vacuna contra la bronquitis infecciosa (divisional de la solicitud no. 201803420)Info
- Publication number
- CL2020002876A1 CL2020002876A1 CL2020002876A CL2020002876A CL2020002876A1 CL 2020002876 A1 CL2020002876 A1 CL 2020002876A1 CL 2020002876 A CL2020002876 A CL 2020002876A CL 2020002876 A CL2020002876 A CL 2020002876A CL 2020002876 A1 CL2020002876 A1 CL 2020002876A1
- Authority
- CL
- Chile
- Prior art keywords
- divisional application
- infectious bronchitis
- bronchitis vaccine
- vaccine
- component
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
- C12N2720/12234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
Una vacuna que comprende un componente de antígeno y un componente adyuvante, en donde el componente adyuvante comprende un oligonucleótido inmunoestimulante y una emulsión de agua-en-aceite (W/O), donde el componente antigénico comprende un virus IBD inactivado, y donde el oligonucleótido inmunoestimulante comprende la SEQ ID NO: 8 en una cantidad de 2,5 a 20 µg por dosis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662344598P | 2016-06-02 | 2016-06-02 | |
US201662365419P | 2016-07-22 | 2016-07-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2020002876A1 true CL2020002876A1 (es) | 2021-05-07 |
Family
ID=59215993
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2018003420A CL2018003420A1 (es) | 2016-06-02 | 2018-11-30 | Vacuna contra la bronquitis infecciosa. |
CL2020002876A CL2020002876A1 (es) | 2016-06-02 | 2020-11-06 | Vacuna contra la bronquitis infecciosa (divisional de la solicitud no. 201803420) |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2018003420A CL2018003420A1 (es) | 2016-06-02 | 2018-11-30 | Vacuna contra la bronquitis infecciosa. |
Country Status (16)
Country | Link |
---|---|
US (2) | US11103573B2 (es) |
EP (1) | EP3463446A1 (es) |
JP (2) | JP2019517526A (es) |
KR (5) | KR20210068601A (es) |
CN (1) | CN109152829A (es) |
AU (1) | AU2017274332A1 (es) |
BR (1) | BR112018075033A2 (es) |
CA (2) | CA3025524C (es) |
CL (2) | CL2018003420A1 (es) |
CO (1) | CO2018012905A2 (es) |
MX (3) | MX2018014857A (es) |
PH (1) | PH12018502525A1 (es) |
RU (1) | RU2021117820A (es) |
UA (1) | UA126562C2 (es) |
WO (1) | WO2017210244A1 (es) |
ZA (3) | ZA201807477B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111303252A (zh) * | 2020-02-17 | 2020-06-19 | 青岛易邦生物工程有限公司 | 一种规模化生产胚毒类抗原的净化方法 |
WO2024077025A1 (en) * | 2022-10-04 | 2024-04-11 | Zoetis Services Llc | Poultry vaccines and methods of protecting poultry |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA978434B (en) * | 1996-09-27 | 1998-03-26 | Akzo Nobel Nv | Inactivated vaccines. |
CA2238659C (en) * | 1997-05-26 | 2010-12-14 | Akzo Nobel N.V. | Recombinant birnavirus vaccine |
US6048535A (en) | 1997-06-12 | 2000-04-11 | Regents Of The University Of Minnesota | Multivalent in ovo avian vaccine |
US8088388B2 (en) | 2002-02-14 | 2012-01-03 | United Biomedical, Inc. | Stabilized synthetic immunogen delivery system |
EP1722814B1 (en) * | 2004-03-12 | 2016-11-09 | Zoetis Services LLC | Infectious bursal disease virus antigenic isolates and vaccines |
GB0428394D0 (en) * | 2004-12-24 | 2005-02-02 | Chiron Srl | Saccharide conjugate vaccines |
MX2009003398A (es) | 2006-09-27 | 2009-08-12 | Coley Pharm Gmbh | Analogos de oligonucleotidos cpg que contienen analogos t hidrofobos con actividad inmunoestimuladora mejorada. |
NZ727616A (en) | 2008-06-27 | 2018-06-29 | Zoetis Services Llc | Novel adjuvant compositions |
AR072976A1 (es) * | 2008-08-08 | 2010-10-06 | Wyeth Corp | Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo |
CN101721698B (zh) | 2008-10-24 | 2014-04-02 | 法罗斯疫苗公司 | 抗口蹄疫疫苗组合物及其制备和应用 |
NZ593220A (en) * | 2008-12-09 | 2012-10-26 | Coley Pharm Group Inc | Immunostimulatory oligonucleotides |
CN102038949A (zh) * | 2010-12-29 | 2011-05-04 | 青岛易邦生物工程有限公司 | 鸡新城疫、传染性支气管炎、减蛋综合征、禽流感(h9亚型)四联灭活疫苗的生产方法 |
EP2471926A3 (en) * | 2010-12-30 | 2012-07-11 | Intervet International BV | Immunostimulatory oligodeoxynucleotides |
EP3777886A1 (en) | 2012-11-16 | 2021-02-17 | United Biomedical Inc. | Synthetic peptide-based emergency vaccine against foot and mouth disease (fmd) |
WO2015042423A2 (en) * | 2013-09-19 | 2015-03-26 | Zoetis Llc | Vaccine |
-
2017
- 2017-05-31 KR KR1020217016599A patent/KR20210068601A/ko not_active Application Discontinuation
- 2017-05-31 KR KR1020227022129A patent/KR20220100725A/ko not_active Application Discontinuation
- 2017-05-31 AU AU2017274332A patent/AU2017274332A1/en active Pending
- 2017-05-31 WO PCT/US2017/035105 patent/WO2017210244A1/en unknown
- 2017-05-31 US US16/309,216 patent/US11103573B2/en active Active
- 2017-05-31 CN CN201780029740.XA patent/CN109152829A/zh active Pending
- 2017-05-31 KR KR1020187032533A patent/KR20180129926A/ko active Application Filing
- 2017-05-31 MX MX2018014857A patent/MX2018014857A/es unknown
- 2017-05-31 RU RU2021117820A patent/RU2021117820A/ru unknown
- 2017-05-31 CA CA3025524A patent/CA3025524C/en active Active
- 2017-05-31 CA CA3175832A patent/CA3175832A1/en active Pending
- 2017-05-31 EP EP17733220.2A patent/EP3463446A1/en active Pending
- 2017-05-31 UA UAA201811848A patent/UA126562C2/uk unknown
- 2017-05-31 JP JP2018563490A patent/JP2019517526A/ja active Pending
- 2017-05-31 KR KR1020227015039A patent/KR20220064417A/ko not_active Application Discontinuation
- 2017-05-31 KR KR1020217016601A patent/KR20210068602A/ko not_active Application Discontinuation
- 2017-05-31 BR BR112018075033-6A patent/BR112018075033A2/pt unknown
-
2018
- 2018-11-07 ZA ZA2018/07477A patent/ZA201807477B/en unknown
- 2018-11-28 CO CONC2018/0012905A patent/CO2018012905A2/es unknown
- 2018-11-29 PH PH12018502525A patent/PH12018502525A1/en unknown
- 2018-11-30 MX MX2022007212A patent/MX2022007212A/es unknown
- 2018-11-30 MX MX2022012910A patent/MX2022012910A/es unknown
- 2018-11-30 CL CL2018003420A patent/CL2018003420A1/es unknown
-
2020
- 2020-11-06 CL CL2020002876A patent/CL2020002876A1/es unknown
-
2021
- 2021-07-13 US US17/374,399 patent/US20220175911A1/en active Pending
-
2022
- 2022-05-06 ZA ZA2022/04979A patent/ZA202204979B/en unknown
- 2022-05-06 ZA ZA2022/04980A patent/ZA202204980B/en unknown
- 2022-09-26 JP JP2022152642A patent/JP2023002541A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
UA126562C2 (uk) | 2022-11-02 |
KR20180129926A (ko) | 2018-12-05 |
MX2018014857A (es) | 2019-03-07 |
RU2018142329A3 (es) | 2020-09-01 |
RU2021117820A (ru) | 2021-07-07 |
CL2018003420A1 (es) | 2019-01-18 |
US11103573B2 (en) | 2021-08-31 |
CA3175832A1 (en) | 2017-12-07 |
BR112018075033A2 (pt) | 2019-03-26 |
US20190240315A1 (en) | 2019-08-08 |
KR20220064417A (ko) | 2022-05-18 |
KR20210068601A (ko) | 2021-06-09 |
PH12018502525A1 (en) | 2019-10-21 |
KR20220100725A (ko) | 2022-07-15 |
AU2017274332A1 (en) | 2018-11-22 |
RU2018142329A (ru) | 2020-06-01 |
WO2017210244A1 (en) | 2017-12-07 |
KR20210068602A (ko) | 2021-06-09 |
ZA201807477B (en) | 2023-06-28 |
EP3463446A1 (en) | 2019-04-10 |
JP2019517526A (ja) | 2019-06-24 |
CA3025524C (en) | 2023-03-07 |
ZA202204980B (en) | 2022-09-28 |
CA3025524A1 (en) | 2017-12-07 |
CN109152829A (zh) | 2019-01-04 |
JP2023002541A (ja) | 2023-01-10 |
CO2018012905A2 (es) | 2018-12-14 |
ZA202204979B (en) | 2022-09-28 |
US20220175911A1 (en) | 2022-06-09 |
MX2022012910A (es) | 2022-11-14 |
MX2022007212A (es) | 2022-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201612316A (en) | Porcine pseudorabies virus gene deletion strain, vaccine composition, and preparation method and application of vaccine composition | |
PH12019501766A1 (en) | Porcine coronavirus vaccines | |
MX2016012845A (es) | Vacuna contra el virus de la diarrea epidemica porcina. | |
CO2019011548A2 (es) | Vacunas contra el gallid herpesvirus 3 recombinante que codifican antígenos patogénicos aviares heterólogos | |
TW201613558A (en) | Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus | |
MX2023000411A (es) | Vacuna combinada de sars-cov-2 e influenza. | |
CL2020002876A1 (es) | Vacuna contra la bronquitis infecciosa (divisional de la solicitud no. 201803420) | |
MX2019007349A (es) | Vacuna combinada para cerdos. | |
AR108829A1 (es) | Vacuna contra virus de bronquitis infecciosa | |
MX2020004543A (es) | Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan. | |
AR056733A1 (es) | Uso de vacunas para el tratamiento / prevencion de la transmision de patogenos | |
NZ739260A (en) | Inactivated canine influenza vaccines and methods of making and uses thereof | |
MX2020005584A (es) | Vacunacion con particulas de replicon y adyuvante oleoso. | |
BR112015022582A2 (pt) | molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo | |
EP4248992A3 (en) | Foot-and-mouth disease vaccine | |
EA201001478A1 (ru) | Вакцина | |
AR097029A1 (es) | Aceleración de la respuesta inmune inducida por virus vectorial en aves, composición, uso, método para la vacunación y método para acelerar la respuesta inmune | |
WO2018066999A3 (en) | Chimeric enterovirus virus-like particles | |
MX2018009956A (es) | Virus de vacuna del sindrome respiratorio y reproductivo porcino. | |
BR112014023283A8 (pt) | Composição imunogênica, segunda composição imunogênica, e, método para prevenção e/ou tratamento contra doença influenza | |
UY36208A (es) | “bacterias modificadas para vacunas mejoradas contra la brucelosis”. | |
UY38933A (es) | Vacuna de partículas tipo virus del chicunguña y métodos para su uso | |
PH12020550948A1 (en) | Vaccines against hendra and nipah virus infection | |
AR108664A1 (es) | Vacuna contra la bronquitis infecciosa | |
MX2020003753A (es) | Composicion nasal de vacuna contra hepatitis b y metodo para producir la misma. |